Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Viral Genome Sequencing Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The viral genome sequencing market size has demonstrated significant expansion in recent years. This market is expected to surge from $6.71 billion in 2025 to $7.72 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.9%. Historically, this growth has been fueled by factors such as the increasing frequency of viral outbreaks, the integration of next-generation sequencing, the advancement of clinical diagnostics, government financial support for research, and the rising demand for epidemiological studies.
The viral genome sequencing market size is anticipated to experience swift expansion over the coming years. It is projected to reach $13.57 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 15.1%. This growth during the projected period can be attributed to several factors, including AI-driven genome analysis, the expansion of vaccine development initiatives, the uptake of portable sequencing technologies, their integration with predictive bioinformatics, and a growing emphasis on real-time pathogen monitoring. Key trends anticipated within this forecast period encompass high-throughput viral genome sequencing, the development of portable sequencing devices, their integration with advanced bioinformatics platforms, automated sample processing, and real-time mutation tracking.
Get A Free Sample Report With In-Depth Market Insights:
Viral Genome Sequencing Market Growth Momentum: What Factors Are Shaping Demand?
The future expansion of the viral genome sequencing market is anticipated to be fueled by the escalating occurrence of infectious diseases. These illnesses, brought on by harmful microorganisms, are experiencing a continuous global increase, driven by factors such as a rise in international travel, urban development, and swift cross-border spread of pathogens. The mounting impact of these diseases has prompted governments and health systems to reinforce their genomic surveillance and outbreak response capacities. Viral genome sequencing is crucial in managing infectious diseases by facilitating quick identification of viral types, tracking genetic changes, mapping transmission routes, and aiding focused public health strategies. For example, in February 2026, data from the Centers for Disease Control and Prevention (CDC), a US-based government department, indicated that in 2026, influenza led to roughly 290,000–450,000 hospitalizations and 34,000–53,000 deaths each year in the United States, alongside RSV causing an estimated 190,000–350,000 hospitalizations and 10,000–23,000 deaths. Consequently, the rising incidence of infectious diseases is set to stimulate the growth of the viral genome sequencing market.
Viral Genome Sequencing Market Breakdown By Product Type And Application
The viral genome sequencing market covered in this report is segmented –
1) By Sequencing Technology: Next-Generation Sequencing, Sanger Sequencing, Third-Generation Sequencing
2) By Sample Type: Blood, Nasal Or Throat Swabs, Saliva, Other Sample Types
3) By Application: Clinical Diagnostics, Research, Epidemiology, Vaccine Development, Other Applications
4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Next-Generation Sequencing: Sequencing By Synthesis, Ion Semiconductor Sequencing, Reversible Terminator Chemistry Sequencing, Targeted Amplicon Sequencing, Whole Genome Shotgun Sequencing
2) By Sanger Sequencing: Capillary Electrophoresis Sequencing, Automated Fluorescent Chain Termination Sequencing, Dideoxy Chain Termination Sequencing, Low Throughput Mutation Verification Sequencing, Plasmid Insert Verification Sequencing
3) By Third-Generation Sequencing: Single Molecule Real Time Sequencing, Nanopore Based Sequencing, Zero Mode Waveguide Sequencing, Long Read Direct Ribonucleic Acid Sequencing, Real Time Field Deployable Sequencing
Viral Genome Sequencing Market Trends Redefining Industry Growth
Leading companies active in the viral genome sequencing market are prioritizing technological advancements in long-read sequencing, such as benchtop long-read sequencing platforms, to achieve a competitive advantage. A benchtop long-read sequencing platform is an integrated laboratory system crafted to generate highly accurate, extended nucleotide sequences from viral genomes within a small footprint, enabling extensive structural variant detection, improved genome assembly, and faster turnaround times for pathogen characterization. This strengthens surveillance capabilities, supports outbreak response efforts, and enhances research precision, although it necessitates higher capital investment and advanced data analysis infrastructure at scale. For instance, in November 2024, Pacific Biosciences, a US-based biotechnology company, unveiled the Revio benchtop HiFi sequencing platform. This platform delivers high-fidelity long reads, offers increased throughput compared to older systems, and features a scalable configuration for clinical and research laboratories, thereby improving viral mutation tracking and genome completeness within the viral genome sequencing market.
Viral Genome Sequencing Market Key Participants And Competitive Landscape
Major companies operating in the viral genome sequencing market are F. Hoffmann‑La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio‑Rad Laboratories Inc., QIAGEN N.V., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Novogene Co. Ltd., Takara Bio Inc., Twist Bioscience Corporation, Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Genewiz, Macrogen Inc., MedGenome Labs Ltd., Eurofins Scientific SE, CD Genomics, BGI Genomics Co. Ltd.
View The Full Viral Genome Sequencing Market Report:
Viral Genome Sequencing Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the viral genome sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral genome sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
